Allogene Therapeutics, Inc. (ALLO)

USD 1.91

(-7.97%)

Annual Balance Sheets

(In USD)
Breakdown 2023 2022 2021 2020 2019 2018
Total Assets 642.83 Million 817.07 Million 1.03 Billion 1.22 Billion 717.8 Million 773.85 Million
Total Current Assets 459.11 Million 528.82 Million 809.48 Million 845.13 Million 544.57 Million 467.98 Million
Cash And Short Term Investments 448.69 Million 576.47 Million 809.48 Million 1.03 Billion 588.85 Million 721.35 Million
Cash and Cash Equivalents 83.15 Million 576.47 Million 809.48 Million 1.03 Billion 588.85 Million 721.35 Million
Short Term Investments 365.54 Million 455.41 Million 283.98 Million 644.55 Million 355.4 Million 366.95 Million
Net Receivables 1.7 Million 3.3 Million 6 Million 2.8 Million 2.4 Million 3.1 Million
Inventory -1.7 Million -62.45 Million -20.02 Million -207 Million -60.72 Million -261.96 Million
Other Current Assets 10.41 Million 11.5 Million 14.02 Million 17.22 Million 14.04 Million 5.49 Million
Total Non-Current Assets 183.72 Million 288.25 Million 229.15 Million 382.69 Million 173.22 Million 305.87 Million
Net PPE 163.18 Million 196.43 Million 181.02 Million 160.13 Million 100.94 Million 41.61 Million
Good Will And Intangible Assets - - - - 151 Thousand 754 Thousand
Good Will - - - - - -
Intangible Assets - - - - 151 Thousand 754 Thousand
Long-Term Investments 3.64 Million 59.15 Million 370.18 Million 207.94 Million 63.21 Million 261.96 Million
Tax Assets - - - - - -
Other Non Current Assets 16.89 Million 32.67 Million -322.05 Million 14.61 Million 8.91 Million 1.54 Million
Other Assets - - - - - -
Total Liabilities 130.6 Million 151.2 Million 122.22 Million 148.21 Million 88.77 Million 70.69 Million
Total Current Liabilities 37.07 Million 54.51 Million 48.17 Million 94.32 Million 33.07 Million 29.45 Million
Account Payables 5.89 Million 13.89 Million 10.25 Million 10.39 Million 9.25 Million 12.33 Million
Tax Payables - - - - - -
Short Term Debt 6.77 Million 6 Million 3.2 Million 2.97 Million - -
Deferred Revenue 86 Thousand 885 Thousand 423 Thousand 38.99 Million - -
Other Current Liabilities 24.32 Million 33.74 Million 34.29 Million 41.96 Million 23.82 Million 17.12 Million
Total Non Current Liabilities 93.52 Million 96.69 Million 74.05 Million 53.89 Million 55.7 Million 41.23 Million
Long-Term Debt 88.34 Million 95.12 Million 69.92 Million 50.8 Million 51.34 Million 34.45 Million
Deferred Revenue Non Current - - - - - -
Deferred Tax Liabilities Non Current - - - - - -
Other Non Current Liabilities 5.17 Million 1.56 Million 4.12 Million 3.08 Million 4.35 Million 6.77 Million
Other Liabilities - - - - - -
Total Equity 512.23 Million 665.87 Million 916.4 Million 1.07 Billion 629.02 Million 703.16 Million
Stock Holders Equity 512.23 Million 665.87 Million 916.4 Million 1.07 Billion 629.02 Million 703.16 Million
Common Stock 169 Thousand 144 Thousand 142 Thousand 140 Thousand 124 Thousand 121 Thousand
Retained Earnings -1.56 Billion -1.23 Billion -903.34 Million -646.34 Million -396.12 Million -211.52 Million
Accumulated other comprehensive income -955 Thousand -9.92 Million -2.56 Million 268 Thousand 1.14 Million 306 Thousand
Common Stock Equity 512.23 Million 665.87 Million 916.4 Million 1.07 Billion 629.02 Million 703.16 Million
Capital Lease Obligation 95.12 Million 95.12 Million 69.92 Million 53.78 Million 51.34 Million 34.45 Million
Total Investments 369.18 Million 514.56 Million 654.17 Million 852.5 Million 418.62 Million 628.91 Million
Total Debt 95.12 Million 95.12 Million 69.92 Million 53.78 Million 51.34 Million 34.45 Million
Net Debt 11.96 Million -481.34 Million -739.55 Million -978.33 Million -537.5 Million -686.89 Million

Balance Sheet Charts